Searching News Database: Titan Pharmaceuticals
HSMN NewsFeed - 2 Oct 2018
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
Titan Strengthens Executive Leadership Team with Appointment of Chief Commercial Officer
HSMN NewsFeed - 14 May 2018
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
Accomplished Global Pharmaceutical Executive, Federico Seghi Recli, Appointed To Titan's Board
HSMN NewsFeed - 22 Jan 2018
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
Titan In Discussions With Braeburn Regarding U.S. Probuphine(R) Commercialization
HSMN NewsFeed - 11 Oct 2017
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease
HSMN NewsFeed - 17 Jun 2011
Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine
Titan Pharmaceuticals Provides Update on Confirmatory Phase 3 Study of Probuphine
HSMN NewsFeed - 28 Jul 2008
FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals
FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals
HSMN NewsFeed - 8 Jul 2008
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer
HSMN NewsFeed - 30 Apr 2008
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
Titan Pharmaceuticals, Inc. Executive Chairman, Dr. Louis R. Bucalo, Retires to Pursue Other Interests
HSMN NewsFeed - 13 Dec 2007
Iloperidone Phase III Clinical Data Demonstrate Efficacy and Favorable Safety and Tolerability Profile
Iloperidone Phase III Clinical Data Demonstrate Efficacy and Favorable Safety and Tolerability Profile
HSMN NewsFeed - 26 Sep 2007
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
Titan Adds Dr. Marc Rubin to Executive Management Team as President and Chief Executive Officer
HSMN NewsFeed - 12 Oct 2006
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Arrowhead Subsidiary, Insert Therapeutics, to Hire Pharmaceutical Executive as Chief Executive Officer
Additional items found! 14
Members Archive contains
14 additional stories matching:
Titan Pharmaceuticals
(Password required)
Titan Pharmaceuticals
(Password required)